{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:12:24Z","timestamp":1780531944263,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aust N Z Health Policy"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Three studies report estimates of the cost and effectiveness of alternate strategies for screening the average-risk Australian population for colorectal cancer. The options considered are faecal occult blood testing, double contrast barium enema, sigmoidoscopy and colonoscopy. At present, there is no consensus over which screening method is optimal by the economic criterion. Also, the existing studies report a mixture of average and incremental cost-effectiveness ratios derived from data collected between 1994 and 2002. We suggest<jats:italic>average<\/jats:italic>cost-effectiveness ratios are not useful for decision-making and illustrate how they differ from the preferred<jats:italic>incremental<\/jats:italic>cost-effectiveness ratio. We then update the cost data reported in the three studies to 2002 prices and calculate incremental cost-effectiveness ratios where not previously available. Our re-analysis of one study contradicts the conclusions drawn by the authors, who had only calculated average cost-effectiveness ratios. In particular, we find their recommendation of population screening with colonoscopy would cause, annually, between 33 and 1,322 years of life to be lost and between $M17 and $M87 to be wasted. Based on updated cost data and the incremental analysis, our findings indicate that population screening using biennial faecal occult blood testing ($39,459 per life-year gained), annual faecal occult blood testing ($30,556 per life-year gained) and colonoscopy ($26,587 per life-year gained) are cost-effective. Hence, the decision over which method of screening is optimal remains ambiguous across the three studies. We recommend policy-makers choose the study they believe produces the most accurate estimates of cost and health effect, identify their willingness to pay for health benefits and consider other issues relevant to the decision.<\/jats:p>","DOI":"10.1186\/1743-8462-2-10","type":"journal-article","created":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T06:25:48Z","timestamp":1116483948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Re-interpreting the data on the cost and effectiveness of population screening for colorectal cancer in Australia"],"prefix":"10.1186","volume":"2","author":[{"given":"Nicholas","family":"Graves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"McKinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Leggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,18]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/j.1753-6405.1996.tb01807.x","volume":"20","author":"G Salkeld","year":"1996","unstructured":"Salkeld G, Young G, Irwig L, Haas M, Glasziou P: Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Australian-and-New-Zealand-journal-of-public-health. 1996, 20: 138-143.","journal-title":"Australian-and-New-Zealand-journal-of-public-health"},{"key":"12_CR2","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0140-6736(96)03386-7","volume":"348","author":"JD Hardcastle","year":"1996","unstructured":"Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, CM M: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996, 348: 1472-7. 10.1016\/S0140-6736(96)03386-7.","journal-title":"Lancet"},{"key":"12_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(96)03430-7","volume":"348","author":"O Kronborg","year":"1996","unstructured":"Kronborg O, Fenger C, Olsen J, Jorgensen OD, S O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996, 348: 1467-71. 10.1016\/S0140-6736(96)03430-7.","journal-title":"Lancet"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9","volume":"7","author":"D Whynes","year":"1998","unstructured":"Whynes D, Neilson A, Walker A, Hardcastle J: Faecal Occult Blood Screening for Colorectal Cancer: Is it cost effective?. Health-Econ. 1998, 7: 21-29. 10.1002\/(SICI)1099-1050(199802)7:1<21::AID-HEC306>3.0.CO;2-9.","journal-title":"Health-Econ"},{"key":"12_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/(SICI)1099-1050(199802)7:1<9::AID-HEC304>3.0.CO;2-H","volume":"7","author":"D Gyrd-Hansen","year":"1998","unstructured":"Gyrd-Hansen D, Sogaard J, K O: Colorectal cancer screening: efficiency and effectiveness. Health-Econ. 1998, 7: 9-20. 10.1002\/(SICI)1099-1050(199802)7:1<9::AID-HEC304>3.0.CO;2-H.","journal-title":"Health-Econ"},{"key":"12_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/0140-6736(93)91181-K","volume":"341","author":"TD Bolin","year":"1993","unstructured":"Bolin TD: Screening for Colorectal Cancer. Lancet. 1993, 341: 1279-10.1016\/0140-6736(93)91181-K.","journal-title":"Lancet"},{"key":"12_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3109\/00365529609094767","volume":"220","author":"TD Bolin","year":"1996","unstructured":"Bolin TD: Cost benefit of early diagnosis of colorectal cancer. Scand-J-Gastroenterol-Suppl. 1996, 220: 142-6.","journal-title":"Scand-J-Gastroenterol-Suppl"},{"key":"12_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5694\/j.1326-5377.1997.tb140068.x","volume":"166","author":"TD Bolin","year":"1997","unstructured":"Bolin TD, Korman MG: How can we reduce the incidence and mortality of colorectal cancer?. Med-J-Aust. 1997, 166: 175-6.","journal-title":"Med-J-Aust"},{"key":"12_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5694\/j.1326-5377.1997.tb138857.x","volume":"167","author":"AJ Kermond","year":"1997","unstructured":"Kermond AJ: How can we reduce the incidence and mortality of colorectal cancer?. Med-J-Aust. 1997, 167: 227-","journal-title":"Med-J-Aust"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1463-1318.1999.00028.x","volume":"1","author":"TD Bolin","year":"1999","unstructured":"Bolin TD, Korman MG, Stanton R, Talley N, Newstead GL, Donnelly N, Hall W, Ho MT, Lapsley H: Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal-Dis. 1999, 1: 113-122. 10.1046\/j.1463-1318.1999.00028.x.","journal-title":"Colorectal-Dis"},{"key":"12_CR11","unstructured":"US Congress Office of Technology Assessment, Cost-effectiveness of colorectal cancer screening in average-risk individuals. Special report. OTA Publication number BP-H-146. 1995, Washington: US Government Printing Office"},{"key":"12_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5694\/j.1326-5377.1999.tb127763.x","volume":"170","author":"TD Bolin","year":"1999","unstructured":"Bolin TD, Cowen AE, Korman MG: Letter. Med-J-Aust. 1999, 170: 283-4.","journal-title":"Med-J-Aust"},{"key":"12_CR13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.5694\/j.1326-5377.2000.tb125674.x","volume":"173","author":"TD Bolin","year":"2000","unstructured":"Bolin TD: Screening for colorectal cancer: FOBT is being superseded. Med-J-Aust. 2000, 173: 334-","journal-title":"Med-J-Aust"},{"key":"12_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5694\/j.1326-5377.2002.tb04340.x","volume":"176","author":"TD Bolin","year":"2002","unstructured":"Bolin TD, Korman MG, Cowen A: Colorectal cancer prevention. Med-J-Aust. 2002, 176: 145-146.","journal-title":"Med-J-Aust"},{"key":"12_CR15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.5694\/j.1326-5377.2001.tb143276.x","volume":"174","author":"TD Bolin","year":"2001","unstructured":"Bolin TD, Lapsley HM, Korman MG: Screening for colorectal cancer \u2013 what is the most cost effective approach?. Med-J-Aust. 2001, 174: 298-301.","journal-title":"Med-J-Aust"},{"key":"12_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5694\/j.1326-5377.2002.tb04939.x","volume":"177","author":"FA Macrae","year":"2002","unstructured":"Macrae FA, Hebbard GS: Colorectal Cancer Prevention. Med-J-Aust. 2002, 177: 527-8.","journal-title":"Med-J-Aust"},{"key":"12_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1440-1746.2004.03177.x","volume":"19","author":"BA O'Leary","year":"2004","unstructured":"O'Leary BA, Olynyk JK, Neville AM, Platell CF: Cost-Effectiveness of Colorectal Cancer Screening: Comparison of Community-Based Flexible Sigmoidoscopy with Fecal Occult Blood Testing and Colonoscopy. J-Gastroenterol-Hepatol. 2004, 19: 38-47. 10.1111\/j.1440-1746.2004.03177.x.","journal-title":"J-Gastroenterol-Hepatol"},{"key":"12_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1148\/radiology.219.1.r01ap3144","volume":"219","author":"PM McMahon","year":"2001","unstructured":"McMahon PM, Bosch JL, Gleason S, Halpern EF, Lester JS, Gazelle GS: Cost-Effectiveness of Colorectal Cancer Screening. Radiology. 2001, 219: 44-50.","journal-title":"Radiology"},{"key":"12_CR19","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"1997","unstructured":"Drummond MF, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes. 1997, Oxford: Oxford University Press, second","edition":"second"},{"key":"12_CR20","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russell LN, Weinstein MC: Cost-effectiveness in Health and Medicine. 1996, New York: Oxford University Press"},{"key":"12_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1136\/bmj.312.7022.35","volume":"312","author":"DJ Torgerson","year":"1996","unstructured":"Torgerson DJ, Spencer A: Marginal costs and benefits. BMJ. 1996, 312: 35-36.","journal-title":"BMJ"},{"key":"12_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJM197507312930504","volume":"293","author":"D Neuhauser","year":"1975","unstructured":"Neuhauser D, Lewicki A: What do we gain from the sixth stool guaiac?. N-Engl-J-Med. 1975, 293: 226-28.","journal-title":"N-Engl-J-Med"},{"key":"12_CR23","unstructured":"Australian Institute of Health & Welfare, Health Expenditure Australia 2001\u201302. 2003, Canberra: Australian Institute of Health and Welfare"},{"key":"12_CR24","unstructured":"TreeAge Software Inc. Data Pro. Williamstown. 2003"},{"key":"12_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-6296(96)00506-1","volume":"16","author":"AM Garber","year":"1997","unstructured":"Garber AM, Phelps CE: Economic foundations of cost-effectiveness analysis. Journal-of-health-economics. 1997, 16: 1-31. 10.1016\/S0167-6296(96)00506-1.","journal-title":"Journal-of-health-economics"},{"key":"12_CR26","unstructured":"Australian Bureau of Statistics, Selected Social and Housing Characteristics for Australia 2001. 2002, Canberra: Australian Bureau of Statistics, Vol. TABLE 3, CAT NOS 2015.0."}],"container-title":["Australia and New Zealand Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-8462-2-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T01:17:16Z","timestamp":1706231836000},"score":1,"resource":{"primary":{"URL":"https:\/\/anzhealthpolicy.biomedcentral.com\/articles\/10.1186\/1743-8462-2-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,18]]},"references-count":26,"aliases":["10.1071\/hp050210"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["12"],"URL":"https:\/\/doi.org\/10.1186\/1743-8462-2-10","relation":{},"ISSN":["1743-8462"],"issn-type":[{"value":"1743-8462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,18]]},"assertion":[{"value":"5 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}